Hearing Loss and Its Burden of Disease in a Large German Cohort-Hearing Loss in Germany.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
09 2022
Historique:
revised: 26 10 2021
received: 12 08 2021
accepted: 02 12 2021
pubmed: 15 12 2021
medline: 20 8 2022
entrez: 14 12 2021
Statut: ppublish

Résumé

Hearing loss is the most common sensory impairment worldwide. It restricts patients in many aspects of their daily lives and can lead to social exclusion. Understanding this burden is a mandatory requirement for the care of those affected. Therefore, the aim of this study was to estimate the burden of hearing loss in a large German cohort. Cohort study. The Gutenberg Health Study is designed as a single-center, prospective, and observational cohort study and representative for the city of Mainz, Germany, with its district. Participants were interviewed concerning common otologic symptoms and tested by pure-tone audiometry. The primary outcome was hearing impairment stratified by age and sex. The prevalence of tinnitus was estimated for a subcohort to calculate disability-adjusted life years (DALYs). All results were weighted by the European Standard Population (ESP) 2013. A total of 5,024 participants (mean age: 61.2 years, 2,591 men and 2,433 women) were included in the study. Hearing impairment showed the following prevalence: 28.2% (95% confidence interval [CI], 26.9%-29.4%) mild impairment, 10.1% (95% CI, 9.3%-11.0%) moderate impairment, 2.3% (95% CI, 1.9%-2.7%) moderately severe impairment, 0.2% (95% CI, 0.1%-0.4%) severe impairment, 0% (95% CI, 0.0%-0.1%) profound impairment, and 0.1% (95% CI, 0.0%-0.2%) complete impairment. Weighted for the ESP 2013 (all ages), hearing impairment across all levels (with/without tinnitus) causes a total of 2,118.97 DALYs per 100,000. With 40.9% affected, the hearing loss represents a relevant burden of the German population. Understanding this will provide the basis for future guidelines on how to care for these patients. 2 Laryngoscope, 132:1843-1849, 2022.

Identifiants

pubmed: 34904723
doi: 10.1002/lary.29980
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1843-1849

Informations de copyright

© 2021 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.

Références

World Health Organization. Deafness and hearing loss. Available at: https://www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss. Accessed May 11, 2021
Nordvik O, Laugen Heggdal PO, Brannstrom J, Vassbotn F, Aarstad AK, Aarstad HJ. Generic quality of life in persons with hearing loss: a systematic literature review. BMC Ear Nose Throat Disord 2018;18:1-18.
Clark J, English K. Counseling in Audiologig Practice: Helping Patients and Families Adjust to Hearing Loss. 1st ed. London: Pearsons; 2003.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet 2020;396:1204-1222.
Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet 2012;380:2063-2066.
Solberg CT, Sørheim P, Müller KE, Gamlund E, Norheim OF, Barra M. The devils in the DALY: prevailing evaluative assumptions. Public Health Ethics 2020;13:259-274.
GBD. 2019 hearing loss collaborators. Hearing loss prevalence and years lived with disability, 1990-2019: findings from the global burden of disease study 2019. Lancet 2021;397:996-1009.
Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the global burden of disease 2013 study. Lancet Glob Health 2015;3:e712-e723.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 2018;392:1789-1858.
World Health Organization. World Report on Hearing. Geneva; 2021 Available at: https://www.who.int/publications/i/item/world-report-on-hearing. Accessed August 7, 2021.
Pascolini D, Smith A. Hearing impairment in 2008: a compilation of available epidemiological studies. Int J Audiol 2009;48:473-485.
Roth TN, Hanebuth D, Probst R. Prevalence of age-related hearing loss in Europe: a review. Eur Arch Otorhinolaryngol 2011;268:1101-1107.
Stevens G, Flaxman S, Brunskill E, et al. Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries. Eur J Public Health 2013;23:146-152.
Centers for Disease Control and Prevention. NIOSH - Occupational noise exposure, revised criteria 1998. Available at: https://www.cdc.gov/niosh/docs/98-126/pdfs/98-126.pdf?id=10.26616/NIOSHPUB98126. Accessed May 11, 2021.
Wild P, Zeller T, Beutel M, et al. Die Gutenberg Gesundheitsstudie [The Gutenberg Health Study]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012;55:824-829.
Chen A, Jacobsen KH, Deshmukh AA, Cantor SB. The evolution of the disability-adjusted life year (DALY). Socioecon Plan Sci 2015;49:10-15.
Mathers C, Smith A, Concha M. Global burden of hearing loss in the year 2000. Available at: https://www.who.int/healthinfo/statistics/bod_hearingloss.pdf. Accessed May 27, 2021.
Eurostat Revision of the European Standard Population. European Commission; 2013; ISSN 1977-0375.
Louw C, Swanepoel W, Eikelboom RH. Self-reported hearing loss and pure tone audiometry for screening in primary health care clinics. J Prim Care Community Health 2018;9:2150132718803156.
Rosati R, Jamesdaniel S. Environmental exposures and hearing loss. Int J Environ Res Public Health 2020;17:4879.
Lohler J, Walther LE, Hansen F, et al. The prevalence of hearing loss and use of hearing aids among adults in Germany: a systematic review. Eur Arch Otorhinolaryngol 2019;276:945-956.
von Gablenz P, Holube I. Prevalence of hearing impairment in northwestern Germany. Results of an epidemiological study on hearing status (HORSTAT). HNO 2015;63:195-214.
Johansson M, Arlinger S. Prevalence of hearing impairment in a population in Sweden. Int J Audiol 2003;42:18-28.
Borchgrevink HM, Tambs K, Hoffman HJ. The Nord-Trondelag Norway audiometric survey 1996-98: unscreened thresholds and prevalence of hearing impairment for adults >20 years. Noise Health 2005;7:1-15.
Quaranta A, Assennato G, Sallustio V. Epidemiology of hearing problems among adults in Italy. Scand Audiol Suppl 1996;42:9-13.
Davis AC. The prevalence of hearing impairment and reported hearing disability among adults in Great Britain. Int J Epidemiol 1989;18:911-917.
de Azeredo Passos VM, Champs APS, Teixeira R, et al. The burden of disease among Brazilian older adults and the challenge for health policies: results of the global burden of disease study 2017. Popul Health Metr 2020;18:14.
Swiaczny Frank. Bundeszentrale für Politische Bildung: Demographic Change in Germany and Europe. Osnabrück, Germany: Institute for Migration Research and Intercultural Studies (IMIS) of the University of Osnabrück; 2013. Available at https://www.bpb.de/gesellschaft/migration/kurzdossiers/177962/germany-and-europe. Accessed October 4, 2021.
Besser J, Stropahl M, Urry E, Launer S. Comorbidities of hearing loss and the implications of multimorbidity for audiological care. Hear Res 2018;369:3-14.
Centers for Disease Control and Prevention. NHANES survey methods and analytic guidelines. Available at: https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx. Accessed May 11, 2021.

Auteurs

Berit Hackenberg (B)

Department of Otorhinolaryngology, University Medical Center Mainz, Mainz, Germany.

Julia Döge (J)

Department of Otorhinolaryngology, University Medical Center Mainz, Mainz, Germany.

Karl J Lackner (KJ)

Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Mainz, Germany.

Manfred E Beutel (ME)

Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Mainz, Mainz, Germany.

Thomas Münzel (T)

Department of Cardiology I, University Medical Center Mainz, Mainz, Germany.

Norbert Pfeiffer (N)

Department of Ophthalmology, University Medical Center Mainz, Mainz, Germany.

Markus Nagler (M)

Preventive Cardiology and Preventive Medicine-Department of Cardiology, University Medical Center Mainz, Mainz, Germany.

Irene Schmidtmann (I)

Institute of Medical Biostatistics, Epidemiology and Informatics, Biometrics Department, University Medical Center Mainz, Mainz, Germany.

Philipp S Wild (PS)

Preventive Cardiology and Preventive Medicine-Department of Cardiology, University Medical Center Mainz, Mainz, Germany.

Christoph Matthias (C)

Department of Otorhinolaryngology, University Medical Center Mainz, Mainz, Germany.

Katharina Bahr (K)

Department of Otorhinolaryngology, University Medical Center Mainz, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH